Annual Total Liabilities
$2.75 M
-$388.00 K-12.36%
December 31, 2023
Summary
- As of February 7, 2025, GLMD annual total liabilities is $2.75 million, with the most recent change of -$388.00 thousand (-12.36%) on December 31, 2023.
- During the last 3 years, GLMD annual total liabilities has fallen by -$5.48 million (-66.58%).
- GLMD annual total liabilities is now -66.58% below its all-time high of $8.23 million, reached on December 31, 2020.
Performance
GLMD Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.51 M
+$960.00 K+61.78%
September 30, 2024
Summary
- As of February 7, 2025, GLMD quarterly total liabilities is $2.51 million, with the most recent change of +$960.00 thousand (+61.78%) on September 30, 2024.
- Over the past year, GLMD quarterly total liabilities has increased by +$423.00 thousand (+20.23%).
- GLMD quarterly total liabilities is now -69.45% below its all-time high of $8.23 million, reached on December 31, 2020.
Performance
GLMD Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
GLMD Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.4% | +20.2% |
| 3 y3 years | -66.6% | +20.2% |
| 5 y5 years | +1.6% | +20.2% |
GLMD Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.0% | at low | -58.8% | +61.8% |
| 5 y | 5-year | -66.6% | at low | -69.5% | +61.8% |
| alltime | all time | -66.6% | +81.2% | -69.5% | +121.3% |
Galmed Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.51 M(+61.8%) |
| Jun 2024 | - | $1.55 M(-12.0%) |
| Mar 2024 | - | $1.76 M(-35.8%) |
| Dec 2023 | $2.75 M(-12.4%) | $2.75 M(+31.5%) |
| Sep 2023 | - | $2.09 M(-23.2%) |
| Jun 2023 | - | $2.72 M(-2.8%) |
| Mar 2023 | - | $2.80 M(-10.7%) |
| Dec 2022 | $3.14 M(-48.6%) | $3.14 M(-38.7%) |
| Sep 2022 | - | $5.12 M(+78.8%) |
| Jun 2022 | - | $2.86 M(-50.9%) |
| Mar 2022 | - | $5.83 M(-4.6%) |
| Dec 2021 | $6.11 M(-25.8%) | $6.11 M(-7.8%) |
| Sep 2021 | - | $6.62 M(-9.6%) |
| Jun 2021 | - | $7.33 M(-1.3%) |
| Mar 2021 | - | $7.42 M(-9.8%) |
| Dec 2020 | $8.23 M(+12.9%) | $8.23 M(+30.7%) |
| Sep 2020 | - | $6.30 M(+26.8%) |
| Jun 2020 | - | $4.96 M(-21.6%) |
| Mar 2020 | - | $6.33 M(-13.1%) |
| Dec 2019 | $7.29 M | $7.29 M(+85.4%) |
| Sep 2019 | - | $3.93 M(+5.5%) |
| Jun 2019 | - | $3.72 M(+28.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $2.91 M(+7.5%) |
| Dec 2018 | $2.71 M(-29.7%) | $2.71 M(+26.5%) |
| Sep 2018 | - | $2.14 M(-43.8%) |
| Jun 2018 | - | $3.80 M(+41.0%) |
| Mar 2018 | - | $2.70 M(-29.9%) |
| Dec 2017 | $3.85 M(-28.4%) | $3.85 M(+22.4%) |
| Sep 2017 | - | $3.15 M(-16.9%) |
| Jun 2017 | - | $3.79 M(-13.1%) |
| Mar 2017 | - | $4.36 M(-19.0%) |
| Dec 2016 | $5.38 M(+97.8%) | $5.38 M(+36.6%) |
| Sep 2016 | - | $3.93 M(+10.0%) |
| Jun 2016 | - | $3.58 M(+11.7%) |
| Mar 2016 | - | $3.20 M(+17.8%) |
| Dec 2015 | $2.72 M(+79.1%) | $2.72 M(+79.6%) |
| Sep 2015 | - | $1.51 M(-10.7%) |
| Jun 2015 | - | $1.70 M(+8.6%) |
| Mar 2015 | - | $1.56 M(+2.8%) |
| Dec 2014 | $1.52 M(-28.3%) | $1.52 M(-48.2%) |
| Sep 2014 | - | $2.93 M(+158.2%) |
| Jun 2014 | - | $1.14 M(-41.1%) |
| Mar 2014 | - | $1.93 M(-8.9%) |
| Dec 2013 | $2.12 M(-22.8%) | $2.12 M |
| Dec 2012 | $2.74 M | - |
FAQ
- What is Galmed Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals annual total liabilities year-on-year change?
- What is Galmed Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly total liabilities year-on-year change?
What is Galmed Pharmaceuticals annual total liabilities?
The current annual total liabilities of GLMD is $2.75 M
What is the all time high annual total liabilities for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual total liabilities is $8.23 M
What is Galmed Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, GLMD annual total liabilities has changed by -$388.00 K (-12.36%)
What is Galmed Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of GLMD is $2.51 M
What is the all time high quarterly total liabilities for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly total liabilities is $8.23 M
What is Galmed Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, GLMD quarterly total liabilities has changed by +$423.00 K (+20.23%)